Table 3.

Morphology and late gadolinium enhancement in the 11 HCM patients

LV morphology & risk factors
Asymmetrical septal hypertrophy n (%)	10 (91%)
Anterior hypertrophy n (%)	1 (9%)
LV outflow tract obstruction at rest n (%)	6 (55%)
Number of risk factors for sudden death: median (range)	0 (0–2)
Presence of late gadolinium enhancement	11 (100%)
Extent of late gadolinium enhancement (% of LV mass)	9.1 ± 3.6%
Location of gadolinium enhancement:
Septum	10 (91%)
Anterior	4 (36%)
Inferior	2 (18%)
Lateral	4 (36%)
> 1 region	8 (73%)